Skip to main content

Life Tech Certifies Asuragen, AltheaDx as Service Providers for Sequencing on PGM


Life Technologies has named both Asuragen and AltheaDx as authorized customer service providers for sequencing on its Ion Torrent PGM platform.

Asuragen offers targeted sequencing panels on the PGM, including its AsuraSeq custom cancer panels and the Ion AmpliSeq cancer panel, and can analyze samples from formalin-fixed paraffin-embedded tissue as well as samples collected from fine needle aspiration (CSN 1/4/2012).

AltheaDx, meantime, is using the PGM in its clinical molecular pathology laboratory for biomarker discovery and clinical trial testing, and offers sequencing services to pharmaceutical and biotechnology companies (CSN 7/6/2011).

Joe Monforte, AltheaDx's chief scientific officer, said in a statement that the company has already begun using the PGM in clinical studies and that it plans to "push ahead several of our companion diagnostic programs based on NGS."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.